Globalive Media

Intelligent Drug Discovery – Tillman Gerngross, Adimab

April 2, 2020 | 3 MINUTES 21 SECONDS

Traditional drug discovery methods are expensive and time-intensive for pharmaceutical companies. Adimab Co-Founder & CEO Tillman Gerngross and Anthony Lacavera discuss how the platform reduces the barriers to drug development.